Loreta A Kondili

Dr. Loreta A Kondili

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2017 in The Lancet Gastroenterology & Hepatology
Verified
Journal Article
Closed access
SBSarah Blach
Sarah Blach
SZStefan Zeuzem
Stefan Zeuzem
MMMichael Manns
Michael Manns
IAIbrahim Altraif
Ibrahim Altraif
ADAnn-Sofi Duberg
Ann-Sofi Duberg
HRHomie Razavi
Homie Razavi

1 June 2018 in The Lancet Gastroenterology & Hepatology
Verified
Journal Article
Closed access
DRDevin Razavi-Shearer
Devin Razavi-Shearer
IGIvane Gamkrelidze
Ivane Gamkrelidze
MNMindie H Nguyen
Mindie H Nguyen
DCDing-Shinn Chen
Ding-Shinn Chen
PDPierre Van Damme
Pierre Van Damme
HRHomie Razavi
Homie Razavi

1 January 2021 in Journal of Hepatology
Verified
Journal Article
Closed access
SBSarah Blach
Sarah Blach
LKLoreta A Kondili
Loreta A Kondili
AAAlessio Aghemo
Alessio Aghemo
ZCZongzhen Cai
Zongzhen Cai
EDEllen Dugan
Ellen Dugan
ACAntonio Craxi
Antonio Craxi

1 May 2017 in The Lancet Gastroenterology & Hepatology
Verified
Journal Article
Closed access
HRHomie Razavi
Homie Razavi
SRSarah Robbins
Sarah Robbins
SZStefan Zeuzem
Stefan Zeuzem
FNFrancesco Negro
Francesco Negro
MBMaria Buti
Maria Buti
AHAngelos Hatzakis
Angelos Hatzakis

11 July 2023 in Biology
Verified
Journal Article
Open access
PDF file
RNRiccardo Nevola
Riccardo Nevola
GTgiovanni Tortorella
giovanni Tortorella
VRValerio Rosato
Valerio Rosato
LRLuca Rinaldi
Luca Rinaldi
SISimona Imbriani
Simona Imbriani
DCDomenico Cozzolino
Domenico Cozzolino
Several chronic liver diseases are characterized by a clear gender disparity. Among them, hepatocellular carcinoma (HCC) shows significantly higher incidence rates in men than in women. The different epidemiological distribution of risk factors for liver disease and HCC only partially accounts for these gender differences. In fact, the liver is an organ with recognized sexual dysmorphism and is extremely sensitive to the action of androgens and estrogens. Sex hormones act by modulating the risk of developing HCC and influencing its aggressiveness, response to treatments, and prognosis. Furthermore, androgens and estrogens are able to modulate the action of other factors and cofactors of liver damage (e.g., chronic HBV infection, obesity), significantly influencing their carcinogenic power. The purpose of this review is to examine the factors related to the different gender distribution in the incidence of HCC as well as the pathophysiological mechanisms involved, with particular reference to the central role played by sex hormones.

1 July 2000 in Journal of Hepatology
Verified
Journal Article
Closed access
GMGiuseppe Maio
Giuseppe Maio
PDPaolo D'ARgenio
Paolo D'ARgenio
TSTommaso Stroffolini
Tommaso Stroffolini
ABAlessandro Bozza
Alessandro Bozza
LSLea Sacco
Lea Sacco
AMAlfonso Mele
Alfonso Mele